(BIM) Biomerieux - Performance 33.8% in 12m

BIM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 15.95%
#22 in Peer-Group
Rel. Strength 80.53%
#1482 in Stock-Universe
Total Return 12m 33.81%
#36 in Peer-Group
Total Return 5y 9.65%
#37 in Peer-Group
P/E Value
P/E Trailing 32.6
P/E Forward 25.6
High / Low EUR
52 Week High 122.50 EUR
52 Week Low 88.10 EUR
Sentiment Value
VRO Trend Strength +-100 72.71
Buy/Sell Signal +-5 -1.42
Support / Resistance Levels
Support
Resistance
12m Total Return: BIM (33.8%) vs XBI (-7.6%)
Total Return of Biomerieux versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (BIM) Biomerieux - Performance 33.8% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
BIM -0.33% 2.27% 5.74%
RGC -7.01% 48.0% 3,117%
SPRO 2.54% 335% 267%
VIGL -0.25% 239% 297%

Long Term Performance

Symbol 6m 12m 5y
BIM 20.1% 33.8% 9.65%
RGC 0.0% 0.0% 5,568%
DRUG -29.0% 2,578% 2.15%
RGLS 395% 242% -13.7%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
10.4% 76.6% 81.6% 23 13.8 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
-6.77% -4.62% 149% 12.9 12 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
9.62% 0.48% 57% 26.8 13.9 0.97 0.60% 41%
BIM PA
Biomerieux
2.27% 33.8% 9.65% 32.6 25.6 1.54 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
3.43% -8.06% 7.86% 42.4 24.4 0.27 18.7% -34.3%
PTCT NASDAQ
PTC Therapeutics
13.1% 44.8% 4.12% 7.86 6.36 0.81 - 68%
KMDA NASDAQ
Kamada
0.29% 36.9% -12% 24.6 20.4 0.81 48.1% 3.93%
ERF PA
Eurofins Scientific SE
8.57% 17.2% 11.2% 28.9 15.1 0.63 -62.1% -19.3%

Performance Comparison: BIM vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIM
Total Return (including Dividends) BIM XBI S&P 500
1 Month 2.27% 7.76% 1.11%
3 Months 5.74% -5.31% 5.58%
12 Months 33.81% -7.58% 10.51%
5 Years 9.65% -18.55% 109.12%

Trend Score (consistency of price movement) BIM XBI S&P 500
1 Month 54.6% 84.2% 69.9%
3 Months 66% -2.8% 69.3%
12 Months 86.8% -77.8% 43.2%
5 Years -15.3% -53.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month #131 -5.09% 1.15%
3 Month #76 11.67% 0.15%
12 Month #36 44.78% 21.08%
5 Years #38 34.63% -47.56%

FAQs

Does Biomerieux (BIM) outperform the market?

Yes, over the last 12 months BIM made 33.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%. Over the last 3 months BIM made 5.74%, while XBI made -5.31%.

Performance Comparison BIM vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

BIM vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.1% 1.2% 21.1% 23%
US NASDAQ 100 QQQ 0.4% 0.8% 21.8% 25%
German DAX 40 DAX 2.3% 3% 4.7% 4%
Shanghai Shenzhen CSI 300 CSI 300 0.4% 3.2% 19.2% 22%
Hongkong Hang Seng HSI -0.4% -2.8% 2% 6%
India NIFTY 50 INDA 1.8% 3.6% 22.1% 35%
Brasil Bovespa EWZ -2.2% 1.8% 0.9% 25%

BIM vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.5% 0.8% 18.3% 11%
Consumer Discretionary XLY 0.7% 4.1% 30.9% 16%
Consumer Staples XLP 0.4% 2.5% 19.6% 27%
Energy XLE -5.8% -0.6% 17.5% 31%
Financial XLF 1.7% 4.8% 18.2% 10%
Health Care XLV -1.8% -2.1% 21.5% 39%
Industrial XLI 1.2% 1.9% 15.5% 16%
Materials XLB 0.8% 0.9% 20.3% 34%
Real Estate XLRE -0.4% 1.3% 20.1% 21%
Technology XLK -0.2% 0.3% 20.7% 30%
Utilities XLU -1.3% 1.7% 12.7% 13%
Aerospace & Defense XAR 1.1% -3.5% 4.1% -9%
Biotech XBI 0.5% -5.5% 31.8% 41%
Homebuilder XHB 1.7% 7.3% 36.5% 43%
Retail XRT 4% 2.4% 29% 33%

BIM vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -11.7% -16.4% 11.2% 31%
Natural Gas UNG 0.9% 4.9% 2.8% 48%
Gold GLD -3.5% -3.9% -9.1% -14%
Silver SLV 0.9% -9.1% 1.5% 11%
Copper CPER 2.6% 0.6% 6.2% 25%

BIM vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -1.4% 1.6% 22.5% 38%
iShares High Yield Corp. Bond HYG -0.4% 1.8% 17.4% 25%